119 related articles for article (PubMed ID: 30676239)
1. Doxorubicin conjugated with nanodiamonds and in free form commit glioblastoma cells to heterodromous fates.
Chen Z; Wang C; Li TF; Li K; Yue Y; Liu X; Xu HZ; Wen Y; Zhang Q; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Nanomedicine (Lond); 2019 Feb; 14(3):335-351. PubMed ID: 30676239
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy.
Li TF; Xu YH; Li K; Wang C; Liu X; Yue Y; Chen Z; Yuan SJ; Wen Y; Zhang Q; Han M; Komatsu N; Zhao L; Chen X
Acta Biomater; 2019 Mar; 86():381-394. PubMed ID: 30654213
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
4. Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
Xu HZ; Li TF; Wang C; Ma Y; Liu Y; Zheng MY; Liu ZJ; Chen JB; Li K; Sun SK; Komatsu N; Xu YH; Zhao L; Chen X
J Nanobiotechnology; 2021 Sep; 19(1):268. PubMed ID: 34488792
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes.
Chen Z; Yuan SJ; Li K; Zhang Q; Li TF; An HC; Xu HZ; Yue Y; Han M; Xu YH; Komatsu N; Zhao L; Chen X
J Control Release; 2020 Apr; 320():469-483. PubMed ID: 31987922
[TBL] [Abstract][Full Text] [Related]
7. Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin.
Yuan SJ; Wang C; Xu HZ; Liu Y; Zheng MY; Li K; Sun SK; Komatsu N; Zhao L; Chen X
Int J Pharm; 2021 Sep; 606():120872. PubMed ID: 34246743
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
[TBL] [Abstract][Full Text] [Related]
9. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
[TBL] [Abstract][Full Text] [Related]
10. Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma.
Zhao D; Yuan H; Yi F; Meng C; Zhu Q
Mol Med Rep; 2014 May; 9(5):1975-81. PubMed ID: 24639013
[TBL] [Abstract][Full Text] [Related]
11. Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling.
Johnson R; Shabalala S; Louw J; Kappo AP; Muller CJF
Molecules; 2017 Sep; 22(10):. PubMed ID: 28937626
[TBL] [Abstract][Full Text] [Related]
12. Nanodiamonds enhance therapeutic efficacy of doxorubicin in treating metastatic hormone-refractory prostate cancer.
Salaam AD; Hwang PT; Poonawalla A; Green HN; Jun HW; Dean D
Nanotechnology; 2014 Oct; 25(42):425103. PubMed ID: 25277401
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1.
Du Y; Liu G; Zhao L; Yao R
Oxid Med Cell Longev; 2020; 2020():8819771. PubMed ID: 33274007
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-mediated chemotherapy drug delivery in glioblastoma.
Wang C; Li K; Li T; Chen Z; Wen Y; Liu X; Jia X; Zhang Y; Xu Y; Han M; Komatsu N; Zhao L; Chen X
Nanomedicine (Lond); 2018 Jan; 13(2):157-178. PubMed ID: 29173008
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy
Li J; Zhou W; Mao Q; Gao D; Xiong L; Hu X; Zheng Y; Xu X
Front Oncol; 2021; 11():739145. PubMed ID: 34778055
[TBL] [Abstract][Full Text] [Related]
16. Construction of doxorubicin-loading magnetic nanocarriers for assaying apoptosis of glioblastoma cells.
Wang X; Wang L; Tan X; Zhang H; Sun G
J Colloid Interface Sci; 2014 Dec; 436():267-75. PubMed ID: 25280371
[TBL] [Abstract][Full Text] [Related]
17. [Autophagy is involved in doxorubicin induced resistance of human myeloma cell line RPMI8226].
Pan YZ; Wang X; Bai H; Wang CB; Zhang Q; Xi R
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):489-92. PubMed ID: 23827103
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
19. Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.
Saiyin W; Wang D; Li L; Zhu L; Liu B; Sheng L; Li Y; Zhu B; Mao L; Li G; Zhu X
Mol Pharm; 2014 May; 11(5):1662-75. PubMed ID: 24666011
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-enhanced delivery of doxorubicin/all-trans retinoic acid-loaded nanodiamonds into tumors.
Li H; Zeng D; Wang Z; Fang L; Li F; Wang Z
Nanomedicine (Lond); 2018 May; 13(9):981-996. PubMed ID: 29536804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
